
A nest egg of $840,000 sits right at the crossroads where dividends and annuities each look surprisingly compelling, and where the wrong choice quietly costs you tens of thousands of dollars over a 20-year retirement.
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

A nest egg of $840,000 sits right at the crossroads where dividends and annuities each look surprisingly compelling, and where the wrong choice quietly costs you tens of thousands of dollars over a 20-year retirement.

Retiring at 65 on dividends sounds straightforward until you realize the number you need today at 55 depends entirely on which yield tier you trust with your financial future, and the wrong choice leaves you no runway to recover.

The yield you chase to replace a six-figure income determines not just how much capital you need, but whether that income holds up a decade from now or quietly erodes beneath you.
Treasuries now yield nearly 5%, raising the stakes for every dividend stock in a boomer portfolio. Five companies have raised their payouts through recessions, inflation spikes, and rate cycles, and the case for owning them lifetime has never required more scrutiny.

Chasing a fatter dividend yield can quietly destroy the very income stream you built it to replace. Before you commit a dollar, understand why the yield number that looks most attractive often signals the greatest danger to your principal.

Building $37,200 a year in dividend income is a math problem first, and the yield tier you choose changes the capital required by hundreds of thousands of dollars in ways most investors never calculate before picking their first stock.

The beauty group's repricing rests on a profit plan it controls, while the low end of its new sales guidance is no faster than the year just ended.
While speculation runs hot and patience gets punished, three Dividend Kings with unbroken raise streaks spanning decades just posted results that made long-term holders take notice, and two of them are sitting at rare discounts heading into September.

Perrigo makes private-label over-the-counter drugs, which sounds like a reliable business, but there are warning signs to consider before you buy it.

In recent weeks, Procter & Gamble’s Charmin and Swiffer brands rolled out new consumer products and campaigns, including the Charmin Forever Roll “Roommate Trials” initiative and the Swiffer Hair Magnet launch with hair expert Jen Atkin. These moves highlight how P&G continues to refresh mature household categories through marketing-led innovation aimed at everyday pain points in shared living and home cleaning. We’ll now examine how P&G’s focus on everyday product innovation, exemplified by...

CLX's GOJO deal boosts fiscal 2027 sales, but inflation, acquisition costs and margin pressure could limit underlying growth.

CLX's GOJO-led growth faces margin pressure, muted core demand and inflation risks, leaving investors focused on a durable recovery.

CLX's rebound faces margin pressure, muted underlying demand and weaker earnings revisions despite GOJO and ERP tailwinds.

CL raised its 2026 profit outlook after a Q2 earnings beat and 140-basis-point margin gain, while higher costs and North America remain risks.

CL enters the second half with better volumes, resilient margins and a higher earnings outlook, but rich valuation and U.S. weakness temper the upside.

Three Dividend Kings with 50-plus years of raises could pay you for decades.

The 3% dividend yield doesn't tell the whole story.

Walmart just flashed a consumer stress signal that income investors cannot afford to ignore, and two Dividend Kings with decades of unbroken payout growth may be the only safe harbor left for retirees watching their portfolio checks.

It's rare for any company to be able to remain in a position to dominate its markets. This one is a compelling exception.

MMM's Consumer segment faces weak demand, but cost management, portfolio strength and innovation could support growth ahead.

Retiring at 55 sounds like freedom, but seven years without a paycheck or Social Security creates a funding gap that destroys most portfolios before the first benefit check ever arrives. The yield tier you choose now determines whether you cross that bridge or fall through it.

The Procter & Gamble Company (NYSE:PG) has reached a milestone that very few companies can match. In April 2026, the consumer staples giant increased its dividend for the 70th consecutive year, extending a record that makes it one of the most dependable dividend companies in the market. P&G has also paid a dividend for 136 […]

Procter & Gamble stock has delivered a 12.7% total return over the past five years, yet current valuation work suggests the shares may still trade below their intrinsic value. The market is weighing that potential upside against recent share price weakness and a mixed overall set of valuation checks. Over the last five years Procter & Gamble has returned 12.7%, which points to modest shareholder gains over a longer holding period rather than a rapid rerating. The planned US$3.8b acquisition...

Colgate-Palmolive Company (NYSE:CL) is often overlooked when investors discuss established dividend stocks. Names such as Coca-Cola, Procter & Gamble, and Johnson & Johnson tend to dominate those conversations. Colgate has a track record that deserves to be mentioned alongside them. It is a Dividend King, with 63 consecutive years of dividend increases and uninterrupted dividend payments […]
While the market chases momentum trades and AI multiples, a small group of blue-chip dividend compounders has quietly raised its payouts for generations and continues doing so in 2026. These five names carry the streaks, the cash flow, and the brand moats to keep rewarding patient investors well into next year.

Looking for dependable dividend stocks? Here are three tickers that could be steady anchors for a long-term portfolio.

Generating $210,000 a year in dividends sounds impossible until you break the portfolio into three distinct yield buckets, each with its own risk profile and capital requirement. The math is brutally simple, but most investors build the wrong blend and wonder why their income stagnates.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.